# Effective Thoracic Duct Ligation at T9 for Postoperative Chylothorax: A Case Report

**Authors:** Yusuke Nabe, Hiroshi Mizuuchi, Masaaki Inoue, Junichi Yoshida

PMC · DOI: 10.7759/cureus.104582 · Cureus · 2026-03-02

## TL;DR

A case report describes a successful surgical technique for treating postoperative chylothorax by ligating the thoracic duct at the T9 level when conventional methods failed.

## Contribution

The paper introduces a novel surgical approach for chylothorax by ligating the thoracic duct at T9 without direct identification.

## Key findings

- Ligation at T9 resolved chylothorax when the thoracic duct could not be identified.
- The T9 level allows en bloc ligation of the thoracic duct with surrounding tissue in challenging cases.
- This method is effective in patients with intrathoracic adhesions or limited diagnostic tools.

## Abstract

Postoperative chylothorax after lung resection and mediastinal lymph node dissection is a rare complication that may be difficult to manage when conservative treatment is ineffective, and the thoracic duct or leak point cannot be identified intraoperatively. Chylothorax is thought to result from thoracic duct injury associated with mediastinal lymph node dissection. Although surgical thoracic duct ligation is recommended in refractory cases, identification of the leakage site or thoracic duct itself is often challenging, particularly in patients with intrathoracic adhesions or in facilities where lymphangiography cannot be performed. An 82-year-old man underwent thoracoscopic right upper lobectomy with mediastinal lymph node dissection for lung adenocarcinoma with mediastinal invasion after induction chemotherapy. Postoperatively, a pulmonary fistula and chylous effusion developed. Although the chylous effusion initially improved with conservative treatment, including a low-fat diet, massive right pleural effusion recurred after discharge. Pleural fluid examination revealed elevated triglyceride levels, leading to a diagnosis of chylothorax. Conservative treatment with dietary restriction and octreotide was ineffective, and thoracoscopic surgery was performed. During the reoperation, severe intrathoracic adhesions and thickening of the mediastinal pleura were observed due to prior surgery and pleurodesis. The areas of previous mediastinal lymph node dissection were carefully examined; however, no clear lymphatic fistula or thoracic duct was observed. Intraoperative intravenous indocyanine green did not delineate the thoracic duct. Because identification of the thoracic duct at the supradiaphragmatic level was considered difficult, the mediastinal pleura was incised at the T8-T9 level, where the thoracic duct anatomically runs between the azygos vein, descending aorta, and esophagus. The adipose tissue containing the presumed thoracic duct was ligated en bloc using silk sutures and resected. Chylous drainage decreased immediately after the procedure, and the chylothorax resolved without recurrence. At the T9 level, posterior mediastinal adipose tissue is relatively limited compared to that at the supradiaphragmatic level, making en bloc ligation feasible even when the thoracic duct cannot be directly identified. Ligation of the thoracic duct together with the surrounding adipose tissue at the T9 level may represent an effective alternative surgical option for postoperative chylothorax in cases where lymphangiography is unavailable or where intrathoracic adhesions make conventional thoracic duct ligation difficult.

## Linked entities

- **Chemicals:** octreotide (PubChem CID 448601), indocyanine green (PubChem CID 5282412)
- **Diseases:** lung adenocarcinoma (MONDO:0005061)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, VEGFC (vascular endothelial growth factor C) [NCBI Gene 7424] {aka Flt4-L, LMPH1D, LMPHM4, VRP}, ADA (adenosine deaminase) [NCBI Gene 100] {aka ADA1}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}
- **Diseases:** exudate (MESH:D011504), cough (MESH:D003371), thoracic duct injury (MESH:D013898), adhesions (MESH:D000267), malnutrition (MESH:D044342), chylous (MESH:D002915), pulmonary fistula (MESH:D005402), lymph node metastases (MESH:D008207), lung cancer (MESH:D008175), empyema (MESH:D004653), adenocarcinoma (MESH:D000230), Malignant tumors (MESH:D009369), inflammatory (MESH:D007249), fatty (MESH:D008067), N2 disease (MESH:D004194), Chylothorax (MESH:D002916), chyle leakage (MESH:D003763), Pleural effusion (MESH:D010996), lymphatic fistula (MESH:D008206), rash (MESH:D005076), lung adenocarcinoma (MESH:D000077192), fatigue (MESH:D005221), pneumonia (MESH:D011014)
- **Chemicals:** pembrolizumab (MESH:C582435), FDG (MESH:D019788), ICG (MESH:D007208), pemetrexed (MESH:D000068437), cisplatin (MESH:D002945), TG (MESH:D013866), ACE (MESH:C024789), glucose (MESH:D005947), MCT (MESH:C000709826), ampicillin/sulbactam (MESH:C035444), minocycline (MESH:D008911), triglyceride (MESH:D014280), Glu (MESH:D018698), cholesterol (MESH:D002784), Octreotide (MESH:D015282)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12954127/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12954127/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12954127/full.md

---
Source: https://tomesphere.com/paper/PMC12954127